Roche Makes Early Headway With Pharmaco-Diagnostics

As discussion of personalized medicine transitions from being a hot new topic to a predominant mentality for R&D, a lot of focus is on Roche to see how the diversified company leverages its dual footholds in the pharmaceutical and diagnostics worlds

More from Archive

More from Pink Sheet